Valvular Disease, Endocarditis, and Cardiomyopathy

  • Celia M. Oakley
Chapter

Abstract

In the 19th century, clinical medicine was firmly based on pathological anatomy. Indeed, in 1846 the Pathological Society of London was founded by physicians rather than pathologists. Pericarditis, valve disease, and endocarditis were described. Fatal conditions became well recognised clinically, benign ones less so. German pathologists and Irish clinicians dominated cardiology in the last century. Although aortic regurgitation was well recognised, other valve deformities were believed to be unimportant.

Keywords

Aortic Stenosis Infective Endocarditis Hypertrophic Cardiomyopathy Left Bundle Branch Block Left Ventricular Outflow Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fleming P. A short history of cardiology. Amsterdam-Atlanta: Editions Rodopi, 1997.Google Scholar
  2. 2.
    Hollman A. Sir Thomas Lewis, pioneer cardiologist and clinical scientist. London: Springer-Verlag, 1992.Google Scholar
  3. 2a.
    Mair A. Sir James Mackenzie MD. Edinburgh: Churchill-Livingstone, 1973.Google Scholar
  4. 3.
    Lewis T. Diseases of the heart. 3rd ed. London: Macmillan, 1944.Google Scholar
  5. 4.
    Wood P. DaCosta’s syndrome or effort syndrome? BMJ 1941;1:767–72, 805–11, 845–51.PubMedCrossRefGoogle Scholar
  6. 5.
    Wood P. Diseases of the heart and circulation. London: Eyre and Spottiswoode, 1950.Google Scholar
  7. 6.
    Osier W. Chronic infectious (sic) endocarditis. Q J Med 1909;2:219–30.Google Scholar
  8. 6a.
    Levy DM. Centenary of William Osier’s 1885 Gulstonian lectures and their place in the history of bacterial endocarditis. J R Soc Med 1985;78:1039–46.PubMedGoogle Scholar
  9. 7.
    Horder TJ. Observations upon the importance of blood culture with an account of the technique recommended. Practitioner 1905;75:611–22.Google Scholar
  10. 8.
    Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701–37.Google Scholar
  11. 9.
    Christie RV. Penicillin in subacute bacterial endocarditis. Report to the MRC. BMJ 1948;i:l–5.Google Scholar
  12. 10.
    Bayliss R, Clarke C, Oakley C, Somerville W, Whitfield AGW. The teeth and infective endocarditis. Br Heart J 1983;50:506–1.PubMedCrossRefGoogle Scholar
  13. 11.
    Working Party of the British society for Antimicrobial Chemotherapy. The antibiotic prophylaxis of infective endocarditis. Lancet 1982;ii:1323–6.Google Scholar
  14. 12.
    Mackenzie J. Diseases of the heart. London: Frowde, 1908.Google Scholar
  15. 13.
    Brigden W. Uncommon myocardial diseases in the non-coronary cardiomyopathies. Lancet 1957;ii:1179–84.CrossRefGoogle Scholar
  16. 14.
    Evans W. Alcoholic cardiomyopathy. Am Heart J 1961;61:556–7.PubMedCrossRefGoogle Scholar
  17. 15.
    Goodwin JF, Gordon H, Hollman A, Bishop MB. Clinical aspects of cardiomyopathy. BMJ 1961;1:69–79.PubMedCrossRefGoogle Scholar
  18. 16.
    Davies LG. A familial heart disease. Br Heart J 1952;14:206.PubMedCrossRefGoogle Scholar
  19. 17.
    Teare RD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1–8.PubMedCrossRefGoogle Scholar
  20. 18.
    Goodwin JF, Hollman A, Cleland WP, et al. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 1960;22:1403.CrossRefGoogle Scholar
  21. 19.
    Brock RC. Functional obstruction of the left ventricle. Guy’s Hosp Rep 1957;106:221.Google Scholar
  22. 20.
    Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211–4.PubMedCrossRefGoogle Scholar
  23. 21.
    Goodwin JF, Oakley CM. The cardiomyopathies. Br Heart J 1972;34:545–52.PubMedCrossRefGoogle Scholar
  24. 22.
    Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS Binding of serum amylase P-component (SAP) by amylase fibrils. Clin Exp. Immunol. 1979;38:284–93.PubMedGoogle Scholar
  25. 23.
    Hawkins PN. The diagnosis, natural history and treatment of amyloidosis. J R Coll Physicians London 1997;31:55–8.Google Scholar
  26. 24.
    Oakley CM. Amyloid heart disease and cardiomyopathies is difficult to classify. In Goodwin J, Olsen E eds. Cardiomyopathies. London: Springer Verlag, 1993:193–214.Google Scholar
  27. 25.
    Ghosh P, Fleming HA, Gresham GA. PG1. Br Heart J 1972;34:769–71.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2000

Authors and Affiliations

  • Celia M. Oakley

There are no affiliations available

Personalised recommendations